The purpose of this paper was to determine the effects of patient characteristics and treatments, storage, and assay type on angiopoietin-1 (Ang-1) and Ang-2 levels in plasma and serum specimens.
Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays.
Lukasz A, Hellpap J, Horn R, Kielstein JT, David S, Haller H, Kümpers P
Purpose
Conclusion
Ang-1 levels were highly correlated between immunoluminometric (ILMA) and immunoradiometric (IRMA) assays. In contrast to the easily detectable levels found in serum, Ang-1 was hardly detectable in EDTA-plasma, even when a calcium supplemented buffer was used. Ang-2 was also lower in EDTA-plasma than in serum, but this difference could be eliminated by using a calcium supplemented buffer. Storage of serum for 24 h at room temperature or 4 degrees C and through up to 4 freeze-thaw cycles did not change Ang-1 or Ang-2 levels. In healthy individuals, Ang-1 and Ang-2 levels in serum did not correlate with age, body mass index, glomerular filtration rate, or serum creatinine, but Ang-1 levels were slightly higher in women than men. In critical care patients, Ang-1 levels were weakly, inversely correlated with the severity of the illness as determined by sequential organ failure assessment (SOFA) scores, while ANG-2 levels were weakly, positively correlated. However, in critical care patients, neither protein was correlated with age or gender. Ang-2 levels showed more variability over the course of 24 h than Ang-1. Antibiotics did not affect Ang-1 or Ang-2 levels, but dialysis decreased Ang-1 and Ang-2 levels by 36.2 and 23.1%, respectively.
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient characteristics and treatments, storage, and assay type on Ang-1 and Ang-2 levels in plasma and serum specimens.
Summary of Findings
Ang-1 levels were highly correlated between ILMA and IRMA (r=0.95). In contrast to the readily detectable levels found in serum, Ang-1 was hardly detectable in EDTA-plasma, even when a calcium supplemented buffer was used. Ang-2 was 20% lower in EDTA-plasma than in serum, but this difference could be eliminated by using a calcium supplemented buffer. Storage of serum for 24 h at room temperature or 4 degrees C and through 4 freeze-thaw cycles did not change Ang-1 or Ang-2 levels. In healthy individuals, Ang-1 and Ang-2 levels in serum did not correlate with age, body mass index, glomerular filtration rate, or serum creatinine, but Ang-1 levels were slightly higher in women than men (p=0.025). In critical care patients, Ang-1 levels were weakly, inversely correlated with the severity of the illness as determined by SOFA scores (r=0.06, p=0.025), while ANG-2 levels were weakly, positively correlated with SOFA scores(r=0.426, p<0.0001). However, in critical care patients, neither protein was correlated with age or gender. Ang-2 levels showed more variability over the course of 24 h than Ang-1. Antibiotics did not affect Ang-1 or Ang-2 levels, but dialysis decreased Ang-1 and Ang-2 levels by 36.2 and 23.1%, respectively.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
NormalOther diagnosesPlatforms
ProteinImmunoradiometric assayProteinImmunoassayProteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Healthy controlIntensive care patient (SOFA 3-22)Preaquisition Other drugs Intravenous antibioticsPreaquisition Patient age 21-69 yearsPreaquisition Patient body mass index 19 to 32 kg/m2Preaquisition Patient gender FemaleMaleBiospecimen Acquisition Time of biospecimen collection 0 h after IV antibiotics0.5 h after IV antibiotics1 h after IV antibiotics10 h after IV antibiotics12 h after IV antibiotics16 h after IV antibiotics2 h after IV antibiotics20 h after IV antibiotics24 h after IV antibiotics4 h after IV antibiotics6 h after IV antibiotics9 h after IV antibioticsAfter dialysisBefore dialysisBiospecimen Aliquots and Components Blood and blood products PlasmaSerumStorage Freeze/thaw cycling 0 cycles4 cyclesStorage Storage duration 0 h0.5 h1 h10 h12 h14 h16 h2 h20 h24 h4 h6 h8 hStorage Storage temperature 4 degrees CRoom temperatureImmunoassay Specific Reaction solution Calcium supplemented bufferRegular bufferImmunoassay Specific Technology platform IRMA